What does Den Baksteen do?

Den Baksteen is a pharmacy in Asse. Public Limited, started on 7 August 1990, 1 establishment.

What is the address of Den Baksteen?

The registered office of Den Baksteen is located at Louwijn 33, 1730 Asse.

Is Den Baksteen still active?

Yes. According to the CBE (30 October 2026) Den Baksteen is active, legal situation “Normale toestand”, started on 7 August 1990.

Is Den Baksteen registered on Peppol?

Yes, Den Baksteen is registered on the Peppol network with ID 0208:0441068601.

What is the enterprise number of Den Baksteen?

The enterprise number of Den Baksteen is BE0441068601.

When was Den Baksteen founded?

Den Baksteen was founded on 7 August 1990.

Who are the directors of Den Baksteen?

According to the 2026 annual accounts, the directors of Den Baksteen are: Farmadil BV.

Is Den Baksteen a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 August 1990; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account.

How much profit did Den Baksteen make in 2026?

Den Baksteen posted a profit after taxes of € 38,615 in financial year 2026.

What is the revenue of Den Baksteen?

As a small company, Den Baksteen is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 107,561.

Den Baksteen (Public Limited) - Asse - BE0441068601

Dossier Den Baksteen, printed on 30 October 2026 from databakkes.be/en/0441068601/den-baksteen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 10 % of short-term debt in 2026; threshold 65 %.

Financials

Financial year 2026

Den Baksteen from Asse, company number BE0441068601, closed financial year 2026 with a result of € 38,615 after tax. For that financial year Den Baksteen recorded a gross margin of € 107,561 and equity of € 579,471. Compared with financial year 2025, the result moved from € 44,920 to € 38,615. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.

What it is worth Growing

€ 579,471

▲ 7% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 38,615

▼ 14% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 14,582

▼ 65% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 517,471.

Debts at end 2026

Bank debt ≈ 15 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 945,167

▼ 6% vs 2025

€ 63,328 is repaid this year. At this pace the long-term loan is gone in ≈ 15 years.

Owed to suppliers

€ 1,973

▲ 218% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,735

▲ 3% vs 2025

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 100,212 Gross margin 2023: € 100,212 First fiscal year in the series	€ 103,055 Gross margin 2024: € 103,055 ▲ 3% vs 2023 (€ 100,212) Favourable step	€ 112,566 Gross margin 2025: € 112,566 ▲ 9% vs 2024 (€ 103,055) Favourable step	€ 107,561 Gross margin 2026: € 107,561 ▼ 4% vs 2025 (€ 112,566) Unfavourable step	▼ 4%
Profit after taxes	€ 30,970 Profit after taxes 2023: € 30,970 First fiscal year in the series	€ 29,538 Profit after taxes 2024: € 29,538 ▼ 5% vs 2023 (€ 30,970) Unfavourable step	€ 44,920 Profit after taxes 2025: € 44,920 ▲ 52% vs 2024 (€ 29,538) Favourable step	€ 38,615 Profit after taxes 2026: € 38,615 ▼ 14% vs 2025 (€ 44,920) Unfavourable step	▼ 14%
Equity	€ 517,398 Equity 2023: € 517,398 First fiscal year in the series	€ 534,436 Equity 2024: € 534,436 ▲ 3% vs 2023 (€ 517,398) Favourable step	€ 540,856 Equity 2025: € 540,856 ▲ 1% vs 2024 (€ 534,436) Favourable step	€ 579,471 Equity 2026: € 579,471 ▲ 7% vs 2025 (€ 540,856) Favourable step	▲ 7%
Total debts	€ 1,155,858 Total debts 2023: € 1,155,858 First fiscal year in the series	€ 1,215,820 Total debts 2024: € 1,215,820 ▲ 5% vs 2023 (€ 1,155,858) Unfavourable step	€ 1,178,186 Total debts 2025: € 1,178,186 ▼ 3% vs 2024 (€ 1,215,820) Favourable step	€ 1,123,963 Total debts 2026: € 1,123,963 ▼ 5% vs 2025 (€ 1,178,186) Favourable step	▼ 5%
Cash	€ 12,246 Cash 2023: € 12,246 First fiscal year in the series	€ 38,077 Cash 2024: € 38,077 ▲ 211% vs 2023 (€ 12,246) Favourable step	€ 41,791 Cash 2025: € 41,791 ▲ 10% vs 2024 (€ 38,077) Favourable step	€ 14,582 Cash 2026: € 14,582 ▼ 65% vs 2025 (€ 41,791) Unfavourable step	▼ 65%
Land & buildings	€ 1,697,324 Land & buildings 2023: € 1,697,324 First fiscal year in the series	€ 1,738,023 Land & buildings 2024: € 1,738,023 ▲ 2% vs 2023 (€ 1,697,324) Unchanged	€ 1,700,773 Land & buildings 2025: € 1,700,773 ▼ 2% vs 2024 (€ 1,738,023) Unchanged	€ 1,699,337 Land & buildings 2026: € 1,699,337 Unchanged (€ 1,700,773) Unchanged
Retained profit	€ 455,398 Retained profit 2023: € 455,398 First fiscal year in the series	€ 472,436 Retained profit 2024: € 472,436 ▲ 4% vs 2023 (€ 455,398) Favourable step	€ 478,856 Retained profit 2025: € 478,856 ▲ 1% vs 2024 (€ 472,436) Favourable step	€ 517,471 Retained profit 2026: € 517,471 ▲ 8% vs 2025 (€ 478,856) Favourable step	▲ 8%
Dividend	€ 0 Dividend 2023: € 0 First fiscal year in the series	€ 12,500 Dividend 2024: € 12,500 Unchanged (€ 0) Unchanged	€ 38,500 Dividend 2025: € 38,500 ▲ 208% vs 2024 (€ 12,500) Unchanged	€ 0 Dividend 2026: € 0 ▼ 100% vs 2025 (€ 38,500) Unchanged	▼ 100%
Bank debt	€ 1,128,012 Bank debt 2023: € 1,128,012 First fiscal year in the series	€ 1,068,925 Bank debt 2024: € 1,068,925 ▼ 5% vs 2023 (€ 1,128,012) Favourable step	€ 1,007,523 Bank debt 2025: € 1,007,523 ▼ 6% vs 2024 (€ 1,068,925) Favourable step	€ 945,167 Bank debt 2026: € 945,167 ▼ 6% vs 2025 (€ 1,007,523) Favourable step	▼ 6%
Balance sheet total	€ 1,728,381 Balance sheet total 2023: € 1,728,381 First fiscal year in the series	€ 1,797,506 Balance sheet total 2024: € 1,797,506 ▲ 4% vs 2023 (€ 1,728,381) Unchanged	€ 1,758,418 Balance sheet total 2025: € 1,758,418 ▼ 2% vs 2024 (€ 1,797,506) Unchanged	€ 1,734,934 Balance sheet total 2026: € 1,734,934 ▼ 1% vs 2025 (€ 1,758,418) Unchanged	▼ 1%

Key figures of Den Baksteen, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to Den Baksteen?

What happened at Den Baksteen in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 14, 2026 New annual accounts for financial year 2026: profit of € 38,615 (▼ 14% vs 2025). Source: NBB ↗
2017 Farmadil BV became a director. NBB
Aug 20, 1990 New establishment in Dilbeek. KBO
Aug 7, 1990 Start of the company according to the CBE. KBO

In short

From € 30,970 profit in 2023 to € 38,615 profit in 2026.

Paid € 48,346 in corporate taxes since 2023.

Best year ever: 2025, with € 44,920 profit.

Paid out € 51,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

FARMADIL 99.8%

The stake of FARMADIL comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Den Baksteen

Behind Den Baksteen is Farmadil BV. The shares are held by FARMADIL (99.8%).

Directors

According to the 2026 annual accounts

Farmadil BV

Gedelegeerd bestuurder · represented by Bruno De Luyck

Also active at: DE MAEYER, De Maeyer Groot-Bijgaarden

since 2017

Shareholders

FARMADIL

99.8%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Louwijn 33

1730 Asse

2.049.283.465

Brusselstraat 456

1702 Dilbeek

Active since 20 August 1990

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

pills for nature

FARMADIL same network

€ 257,984 gross margin · 2025

Farmadec

€ 45,948 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0441.068.601

VAT number

BE 0441.068.601

Registered office

Louwijn 33, 1730 Asse

Names & denominations

Den Baksteen

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

7 August 1990

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Den Baksteen

Warning lights

Financials

What happened to Den Baksteen?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions